104 related articles for article (PubMed ID: 28737230)
1. Endometrial cytopathology. An image analysis approach using the Ki-67 biomarker.
Apostolou G; Apostolou N; Moulos P; Chatzipantelis P
Cytopathology; 2017 Oct; 28(5):385-390. PubMed ID: 28737230
[TBL] [Abstract][Full Text] [Related]
2. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
3. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
4. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2013 Mar; 41(3):212-7. PubMed ID: 21965052
[TBL] [Abstract][Full Text] [Related]
6. Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki-67 and p53 biomarkers.
Apostolou G; Apostolou N; Nikolaidou C; Kavantzas N; Patsouris E; Athanassiadou P
Cytopathology; 2014 Apr; 25(2):86-94. PubMed ID: 24118263
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
8. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
9. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
10. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
11. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
[TBL] [Abstract][Full Text] [Related]
12. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
13. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
[TBL] [Abstract][Full Text] [Related]
14. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
[TBL] [Abstract][Full Text] [Related]
15. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
16. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
Gurda GT; Baras AS; Kurman RJ
Int J Gynecol Pathol; 2014 Mar; 33(2):114-9. PubMed ID: 24487464
[TBL] [Abstract][Full Text] [Related]
18. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
19. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
Yan B; Zhao T; Liang X; Niu C; Ding C
Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
[TBL] [Abstract][Full Text] [Related]
20. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
